Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Heart Failure Clinical Trials

A listing of Heart Failure medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (821) clinical trials

To evaluate the effect of treatment with omecamtiv mecarbil (OM) compared with placebo on the time to cardiovascular (CV) death or first HF (Heart Failure) event, whichever occurs first, in subjects with chronic HF with reduced ejection fraction (HFrEF) receiving standard of care (SoC) therapy.

Phase N/A

To evaluate the efficacy of the oral soluble guanylate cyclase (sGC) stimulator MK-1242 (vericiguat) in comparison to placebo on a background of standard of care in increasing the time to first occurrence of the composite of CV death or HF hospitalization in subjects with HFrEF.

Phase N/A

Don't wait, participate! A clinical trial for heart failure is now enrolling. Play an active role in your health care and contact us to see if you qualify to participate in this trial.

Phase

Don't wait, Participate! A clinical trial for those with heart failure is now enrolling. Play an active role in your health care and contact us to see if you qualify to participate in this study.

Phase N/A

Researchers at the University of Kentucky Gill Heart & Vascular Institute are inviting you to participate in a clinical research study evaluating an investigational implantable device designed to send electrical signals to balance the cardiovascular system. To learn more, visit: www.HeartFailureStudy.com

Phase N/A

This study is designed as a multi-center prospective observational study of diagnosed Heart Failure (HF) patients to test the hypothesis that additional Ejection Fraction (EF) recovery occurs between 90 and 180 days as Guideline Directed Medical Therapy (GDMT) is achieved.

Phase N/A

Cardiac MRI for Optimal Heart Failure Outcomes With CRT Upgrades

The scientific premise of this proposal is that left and right ventricular (LV and RV) structural characteristics in patients with existing cardiac implantable electronic devices and heart failure who may benefit from an upgrade to a cardiac resynchronization therapy (CRT) device can be assessed very effectively using cardiac MRI using ...

Phase

PARTNER 3 Trial - Mitral Valve in Valve

A prospective, single-arm, multicenter clinical trial. This study will enroll patients with symptomatic heart disease due to a failing bioprosthetic mitral valve (stenosed, insufficient, or combined).

Phase N/A

Intravenous Iron in Patients With Systolic Heart Failure and Iron Deficiency to Improve Morbidity & Mortality

The clinical trial is designed as an international, prospective, multi-centre, double-blind, parallel group, randomised, controlled, interventional trial to investigate whether a long-term therapy with i.v. iron (ferric carboxymaltosis) compared to placebo can reduce the rate of recurrent heart failure hospitalisations and cardiovascular (CV) death in patients with heart failure with ...

Phase

Plasma Catestatin Expression and Cardiometabolic Parameters in Patients With Congestive Heart Failure

The congestive heart failure (HF) is a condition associated with substantial morbidity, mortality, and high healthcare expenditures. From the pathophysiological standpoint, several mechanisms contribute to the progression and dysfunction of the failing heart such as an increased hemodynamic overload, impaired myocyte calcium cycling, upregulated apoptotic activity, deficient or increased production ...

Phase N/A